The frequency of RAS mutation in circulating tumor DNA predicts worse survival in patients with mCRC

Lu Yang(Wuhan University), Yanhong Deng(Sun Yat-sen University), Ruijie Deng(Tsinghua University), Jun Zhang(Tencent (China)), Haixia Hu(Sun Yat-sen University), Yue Cai(Sun Yat-sen University), Zehua Wu(Shanghai Jiao Tong University)
Annals of Oncology
September 1, 2017
Cited by 0


Related Papers